The Influence of Technology Orientation on Firm Performance: The Mediating Role of Dynamic Capabilities in a Dynamic Pharmaceutical Environment

Clicks: 7
ID: 336304
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #355 of 953 articles by views in Pakistan Social Sciences Review

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 953 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
This study investigates how technology orientation influences firm performance through the mediating role of dynamic capabilities within Pakistan’s dynamic pharmaceutical environment. Although the Resource-Based View and Dynamic Capabilities View highlight the importance of strategic resources, limited empirical work integrates technology orientation with capability development. Rapid technological shifts in pharmaceuticals make this linkage critical. A quantitative approach was used, drawing data from 180 pharmaceutical firms. Partial least squares structural equation modeling (PLS-SEM) evaluated direct, indirect, and moderating relationships among technology orientation, dynamic capabilities, firm performance, and environmental dynamism. Technology orientation significantly improves firm performance both directly and by strengthening sensing, seizing, and reconfiguring capabilities. Dynamic capabilities also show a strong positive impact on performance. Environmental dynamism, however, does not significantly moderate the dynamic capabilities–performance relationship. Pharmaceutical firms should invest in both technological advancement and capability-building systems. Future studies should adopt longitudinal designs and cross-industry or cross-national comparisons.
Reference Key
imported_1793230660_6ae287442b2d7 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Tayyebah Sehar
Are you one of these authors? Claim your profile
Journal Pakistan Social Sciences Review
Year 2026
DOI
10.35484/pssr.2026(10-II)08
URL
https://ojs.pssr.org.pk/journal/article/view/1263
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.